Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Drug Targeting is Scopus-indexed (Q1, CiteScore 8.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1029-2330Verify ISSN ↗1061-186XVerify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 36 / 191 | 81st | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1992–present (also 1986–1987), best quartile Q1, CiteScore 8.5.
Journal of Drug Targeting is Q1 in Pharmaceutical Science (rank 36 of 191), by CiteScore 2025.
Journal of Drug Targeting is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.5, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.829, quartile Q1, with an H-index of 116.
Journal of Drug Targeting is published by Taylor and Francis Ltd. Its print ISSN is 1029-2330 and its online ISSN is 1061-186X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Drug Targeting has an h-index of 120 and a 2-year mean of 5.31 citations per paper (OpenAlex). Its Scopus CiteScore is 8.5, quartile Q1. On 2-year citations it ranks #31 of 177 Scopus journals in Pharmaceutical Science.
Journal of Drug Targeting published 159 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2026), authors are most often from China (27.2%), India (25.2%) and Egypt (11.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 19 retracted papers are recorded (6.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.